|Rat Target Sites||Mouse Target Sites||TD50 (mg/kg/day)|
|no positive||no positive||liv||liv||no positive||12.5m|
|Hamster Target Sites||TD50
Key to the Table Above
The Carcinogenic Potency Database (CPDB) is a unique and widely used international resource of the results of 6540 chronic, long-term animal cancer tests on 1547 chemicals. The CPDB provides easy access to the bioassay literature, with qualitative and quantitative analyses of both positive and negative experiments that have been published over the past 50 years in the general literature through 2001 and by the National Cancer Institute/National Toxicology Program through 2004. The CPDB standardizes the diverse literature of cancer bioassays that vary widely in protocol, histopathological examination and nomenclature, and in the published author’s choices of what information to provide in their papers. Results are reported in the CPDB for tests in rats, mice, hamsters, dogs, and nonhuman primates.
For each experiment, information is included on species, strain, and sex of test animal; features of experimental protocol such as route of administration, duration of dosing, dose level(s) in mg/kg body weight/day, and duration of experiment; experimental results are provided on target organ, tumor type, and tumor incidence; carcinogenic potency (TD50) and its statistical significance; shape of the dose-response, author’s opinion as to carcinogenicity, and literature citation.
Only tests with dosing for at least ¼ the standard lifespan of the species and experiment length at least ½ the lifespan are included in the CPDB. Only routes of administration with whole body exposure are included. Doses are standardized, average dose rates in mg/kg/day. A description of methods used in the CPDB to standardize the diverse literature of animal cancer tests is presented for: 1) Criteria for inclusion of experiments 2) Standardization of average daily dose levels and 3) TD50 estimation for a standard lifespan. See Methods for other details.
TD50 provides a standardized quantitative measure that can be used for comparisons and analyses of many issues in carcinogenesis. The range of TD50 values across chemicals that are rodent carcinogens is more than 100 million-fold. More than half the chemicals tested are positive in at least one experiment.
A plot of all results on each experiment in the CPDB for this chemical is presented below. These results are the source information for the Cancer Test Summary table above.
Chemical (Synonym) CAS # Species Sex Strain Route Xpo+Xpt PaperNum 0 Dose 1 Dose 2 Dose 3 Dose Literature Reference or NCI/NTP:Site Path Site Path Notes TD50 DR Pval AuOp LoConf UpConf Cntrl 1 Inc 2 Inc 3 Inc Brkly Code
p,p'-DDE 72-55-9 1706 H f syg eat 28m28 1556 0 52.3mg 105.mg Rossi;canr,43,776-781;1983 liv nnd e 354.mg * P<.003 + 166.mg 1.76gm 0/31 4/26 5/24 adr mix e 458.mg * P<.03 205.mg n.s.s. 2/42 7/39 8/39 lun tum e no dre P=1. 1.13gm n.s.s. 2/42 0/39 1/39 tba mix e 634.mg * P<.4 163.mg n.s.s. 13/42 13/39 16/39 1707 H m syg eat 28m28 1556 0 46.0mg 92.0mg liv nnd e 141.mg * P<.04 + 77.0mg n.s.s. 0/10 7/15 8/24 lun tum e no dre P=1. 273.mg n.s.s. 1/31 0/30 0/39 tba mix e 1.30gm * P<.8 136.mg n.s.s. 15/31 11/30 20/39 1708 M f b6c eat 78w92 TR131 : 0 15.6mg 28.6mg liv hpc dv 9.45mg / P<.0005 c 6.69mg 14.3mg 0/20 19/50 34/50 TBA MXB dv 11.9mg / P<.0005 7.31mg 32.8mg 5/20 25/50 35/50 liv MXB dv 9.45mg / P<.0005 6.69mg 14.3mg 0/20 19/50 34/50 liv:hpa,hpc,nnd. lun MXB dv no dre P=1. n.s.s. n.s.s. 0/20 0/50 0/50 lun:a/a,a/c. 1709 M m b6c eat 78w92 TR131 : 0 15.6mg 26.4mg liv hpc dsv 11.1mg * P<.03 c 6.68mg n.s.s. 0/20 7/50 17/50 TBA MXB dsv 7.48mg * P<.05 4.86mg n.s.s. 0/20 15/50 22/50 liv MXB dsv 11.1mg * P<.03 6.68mg n.s.s. 0/20 7/50 17/50 liv:hpa,hpc,nnd. lun MXB dsv 119.mg * P<.5 35.8mg n.s.s. 0/20 1/50 2/50 lun:a/a,a/c. 1710 M f cf1 eat 25m25 80 0 32.5mg Tomatis;jnci,52,883-891;1974 liv hpt 10.5mg P<.0005 + 6.80mg 16.3mg 1/97 54/60 lun mix no dre P=1. - 231.mg n.s.s. 37/97 9/60 tba mix 14.8mg P<.0005 8.34mg 32.3mg 48/97 54/60 1711 M m cf1 eat 25m25 80 0 30.0mg liv hpt 33.9mg P<.0005 + 18.4mg 103.mg 33/101 39/60 lun mix no dre P=1. - 136.mg n.s.s. 53/101 19/60 tba mix no dre P=1. 35.9mg n.s.s. 89/101 48/60 1712 R f osm eat 18m26 TR131 : 0 8.40mg 14.4mg thy MXA dev# 33.2mg * P<.04 - 15.5mg n.s.s. 2/20 9/50 12/50 thy:fca,fcc. S TBA MXB dev 58.0mg * P<.7 9.00mg n.s.s. 16/20 36/50 29/50 liv MXB dev no dre P=1. n.s.s. n.s.s. 0/20 0/50 0/50 liv:hpa,hpc,nnd. 1713 R m osm eat 18m26 TR131 : 0 12.0mg 23.2mg TBA MXB dv 48.1mg * P<.4 - 13.6mg n.s.s. 9/20 21/50 20/50 liv MXB dv no dre P=1. n.s.s. n.s.s. 0/20 0/50 0/50 liv:hpa,hpc,nnd.
See full CPDB Summary Table on 1547 chemicals. See Full CPDB for all results on 6540 experiments of 1547 chemicals.
A complete list of CPDB chemicals, which is searchable by name or by CAS number, is available here.
For a compendium of CPDB results organized by target organ, which lists all chemicals in each species that induced tumors in each of 35 organs, see Summary Table by Target Organ.
The CPDB is available in several formats that permit printing and downloading into spreadsheets and statistical databases.
A Supplementary Dataset gives details on dosing and survival for each experiment.
Relatively precise estimates of the lower confidence limit on the TD10 (LTD10) are readily calculated from the TD50 and its lower confidence limit, which are reported in the CPDB. For researchers and regulatory agencies interested in LTD10 values, we provide them in an Excel spreadsheet.
PDF versions of our publications of analyses using the CPDB are available, organized by year and by research topic.